Clinical Trials · NCT03795701
To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Texas Tech University
- Enrollment
- 73
- Start date
- Jan 2019
- Locations
- 2 sites, United States
- Primary endpoint
- Compare the changes of pre-prandial fMRI-FCR in Liraglutide 3.0 vs. Placebo Group